{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:4091",
      "entity_text" : "metformin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Research shows that metformin can reduce brain tissue inflammation through the AMPK pathway, and reduce the production of inflammatory cytokines, thereby reducing damage to the blood-brain barrier and promoting nerve repair [XREF_BIBR, XREF_BIBR - XREF_BIBR].",
  "reading_complete" : "2020-08-04T18:59:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T18:56:51Z",
  "trigger" : "reduce",
  "evidence" : [ "metformin can reduce brain tissue inflammation" ],
  "pmc_id" : "6442495",
  "score" : 0
}